Robert Kang
Otolaryngology · Los Angeles, CANPI 1316059348
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,350 of the $3,011 with a category attached, or 78.1%. 15 manufacturers reported payments, led by Stryker at 50.2% of the total.
Across 43 payments — averaging $70.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- AbbVie$446
- Acera Surgical, Inc.$355
- Axogen$139
- Integra Lifesciences Corporation$135
- Kls-martin L.p.$125
- plus $300 from 9 others
Across 21 payments — averaging $2564.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$54K
What the payments were for
- Travel & lodging$66122%
- Food & beverage$2,35078%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 17 | $1,511 |
| AbbVie | 3 | $446 |
| Acera Surgical, Inc. | 6 | $355 |
| Axogen | 2 | $139 |
| Integra Lifesciences Corporation | 2 | $135 |
| Kls-martin L.p. | 1 | $125 |
| AstraZeneca | 3 | $55 |
| Medtronic | 1 | $49 |
| Merck | 2 | $49 |
| Smith+Nephew | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Bayer | 1 | $23 |
| Novartis | 1 | $23 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$944
- BOTOX$300
- Restrata Wound Matrix$163
How this compares
$3,011 in reported general payments places this provider in the 75th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Los Angeles
- Keith BlackwellLos Angeles$349K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Elisabeth FerenceLos Angeles$111K
- Arthur WuLos Angeles$67K
- Richard MichelinLos Angeles$57K
- Maie St JohnLos Angeles$39K
- Kevin GrafmillerLos Angeles$27K
- Philip KnottLos Angeles$24K
- Uttam SinhaLos Angeles$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.